TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive AICR Increasing Funds for Research, Education, Supports Successful Symposium November 7, 1986
TCL Archive Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics January 3, 2014
